NICE recommends first ever treatment for children with rare muscle-wasting condition
Children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with nusinersen after NICE today (15 May) recommended it following agreement of a deal between the company, Biogen, and NHS England.
Lower price for MS drug paves the way for positive recommendation from NICE
A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults has paved the way for its approval by NICE
New NICE guideline will help doctors recognise and refer people with suspected neurological conditions
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
NICE launches online resource to help development and adoption of new health technologies
HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).
Latest news headlines
-
Department of Health and Social Care seeks new Chair to lead NICE Board
Applications must be received by midday on 7 May 2019
16 April 2019
-
Offer women a choice of procedure to terminate their pregnancy
All women should be able to access both medical and surgical procedures to terminate their pregnancy, says NICE in draft guidance.
12 April 2019
-
NICE encourages use of greener asthma inhalers
People with asthma will be helped to choose the inhaler that is best for them, and best for the environment, by a new patient decision aid from NICE
08 April 2019
-
20 years of NICE
Founded in April 1999, the organisation has grown from one man with a borrowed laptop to a world leader in health technology assessment and guidance.
01 April 2019
-
NICE publishes a summary of its guidance and other safety advice on valproate
NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.
28 March 2019
-
Promising lung cancer treatment approved for Cancer Drugs Fund
A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.
28 March 2019